HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elias B Rashu Selected Research

Type 2 Diabetes Mellitus (MODY)

10/2022Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elias B Rashu Research Topics

Disease

2Non-alcoholic Fatty Liver Disease
01/2023 - 01/2023
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
04/2024
1Hyperinsulinism (Hyperinsulinemia)
04/2024
1Insulin Resistance
04/2024
1Liver Diseases (Liver Disease)
04/2024
1Sclerosing Cholangitis
04/2024
1Autoimmune Hepatitis
04/2024
1Fibrosis (Cirrhosis)
01/2023
1Type 2 Diabetes Mellitus (MODY)
10/2022
1Heart Failure
10/2022

Drug/Important Bio-Agent (IBA)

3Glucose (Dextrose)FDA LinkGeneric
04/2024 - 10/2022
2Glucagon-Like Peptide 1 (GLP 1)IBA
04/2024 - 10/2022
2Glucagon (Glukagon)FDA Link
01/2023 - 01/2023
1Insulin (Novolin)FDA Link
04/2024
1IncretinsIBA
04/2024
1C-PeptideIBA
01/2023
1Glucagon Receptors (Glucagon Receptor)IBA
01/2023
1fibroblast growth factor 21IBA
01/2023
1Neprilysin (Neutral Endopeptidase)IBA
10/2022
1Pancreatic HormonesIBA
10/2022
1sacubitril and valsartan sodium hydrate drug combinationIBA
10/2022
1Angiotensin Receptor AntagonistsIBA
10/2022